Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis.
about
Monocytes in atherosclerosis: subsets and functionsMonocyte heterogeneity in cardiovascular diseaseRegulation of atherogenesis by chemokines and chemokine receptorsMinireview: Emerging Concepts in Islet Macrophage Biology in Type 2 DiabetesThe ischemic environment drives microglia and macrophage functionThrombin and vascular inflammationMonocytes link atherosclerosis and cancerStatins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophagesDistinct kinin-induced functions are altered in circulating cells of young type 1 diabetic patientsMonocyte recruitment during infection and inflammationDo not let death do us part: 'find-me' signals in communication between dying cells and the phagocytes.Heterogeneity of lung mononuclear phagocytes during pneumonia: contribution of chemokine receptorsSyk regulates multiple signaling pathways leading to CX3CL1 chemotaxis in macrophages.Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiationIn vivo imaging implicates CCR2(+) monocytes as regulators of neutrophil recruitment during arthritisAdrenergic-mediated loss of splenic marginal zone B cells contributes to infection susceptibility after strokeCX3CR1 deficiency does not influence trafficking of adipose tissue macrophages in mice with diet-induced obesity.The temporal dynamics of plasma fractalkine levels in ischemic stroke: association with clinical severity and outcomeThe journey from stem cell to macrophage.Monocytes: protagonists of infarct inflammation and repair after myocardial infarctionCXCR3-dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stressesTwo polymorphisms in the Fractalkine receptor CX3CR1 gene influence the development of atherosclerosis: a meta-analysisLeukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?Lifestyle effects on hematopoiesis and atherosclerosis.Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regressionThe macrophage: the intersection between HIV infection and atherosclerosis.Innate immunity and monocyte-macrophage activation in atherosclerosis.Genetic deletion of chemokine receptor Ccr6 decreases atherogenesis in ApoE-deficient mice.Deficiency of the sialyltransferase St3Gal4 reduces Ccl5-mediated myeloid cell recruitment and arrest: short communicationDual targeting of CCR2 and CX3CR1 in an arterial injury model of vascular inflammation.Progenitor cells in pulmonary vascular remodeling.Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.Shape descriptors of the "never resting" microglia in three different acute brain injury models in mice.Fractalkine is a novel human adipochemokine associated with type 2 diabetesSerum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation.Genetic basis of atherosclerosis: insights from mice and humansRole of the CX3C chemokine receptor CX3CR1 in the pathogenesis of atherosclerosis after aortic transplantationCX3CR1 deficiency promotes muscle repair and regeneration by enhancing macrophage ApoE production
P2860
Q22251045-7F204FFA-C209-4ED0-90F0-27C56C97BC41Q26991973-648C942D-6EB1-4FFE-8068-380904A1AAF3Q27003124-5F2F15AC-6358-46A9-992B-1DEC0D74CD33Q28083768-D1248E27-A178-4F03-96EC-B88EAAAA8504Q28086874-94AF826C-CC6C-460F-A579-C29EAC8507A2Q28246124-B91B2E08-FDD4-43F5-95CC-24E8B9FB05E1Q28390589-98776FEC-CA5A-4AF1-9DB5-555C3D74B210Q28741815-A804F788-695D-4989-B5B7-91C4EAA01BBEQ28751480-3C6C2E72-ED34-4A4D-BA40-20346B0D6A65Q29620067-DB160BAC-8CBD-4A01-854C-351EF2ADC87EQ30277318-C48D2BB5-9E22-466A-AD2B-5BFF09831DB1Q30409523-30D52C2F-D71B-4851-841B-71A29740E06DQ30427232-FDDCC3DB-F73A-4FE0-A591-CA1B838D389AQ30433016-6FB80A7B-ABA9-4812-B8F9-63E142DC75ACQ30543940-A4D6E0E6-3B40-408C-AE78-25AB2F7BF878Q30846614-6FD657AA-5F30-4CAA-8B45-521C446EAC8DQ33554073-4413FE3A-54E9-41D5-A796-BAF1C14BF424Q33615950-E3E95C75-F5B4-4279-97F7-AFA389E38460Q33817936-623D5691-ADA2-4B56-9E3B-A2F2DCF21EDBQ33942337-BED95F15-BDB1-4234-BDF7-7F97946D2E4CQ34096557-58BFD4A1-FB53-4073-92AF-AC3F291D5B38Q34152811-D033C42A-3673-4260-B8FF-564873CC9071Q34322056-C50CB57D-DFBD-43DD-A15D-B2DE09B6B361Q34550041-5F8DBF97-E3E4-4288-AB64-EF213379F3F1Q34668164-2ECB760B-27AD-41C2-809D-B5CC3330950DQ34876397-E22708C9-E6FA-4D86-914E-77F42DA8CE3BQ34898069-69FDEFD0-6B4F-47FC-923E-4AC24201CCD6Q34980214-9BB76A45-E99E-48EB-8E01-19A060455679Q35151086-333E817D-1FFA-4696-8620-FFB936A36B33Q35159004-B0AB895A-25BD-4DED-A27D-91BC110B3B1BQ35180109-A5C5CCA8-98D0-4973-8509-60D528C6172DQ35412268-719740E8-160E-47F5-B443-937F25A89535Q35640438-DE91A329-E1BC-4466-872F-BFF19CF32AF5Q35717479-90E3213C-1E2A-4EBB-9D6C-5FAD91088A27Q35796996-0A74059A-05EA-47CF-B812-082209D6D650Q35893544-4B3DFF77-5A30-4706-9BF8-2D4B5437A7E7Q35952700-AE2C951D-05D9-4EC5-8D8F-14EBD5693CC5Q35975437-CCEB1D9F-7A4A-4D9D-A6C3-BD7D25C20005Q36289475-805A55BB-89FB-4538-9527-E3625FF4B6C8Q36392588-75D61B8B-0DC8-4EEB-9C9F-4D634FDE223B
P2860
Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Fractalkine deficiency markedl ...... ne functions in atherogenesis.
@ast
Fractalkine deficiency markedl ...... ne functions in atherogenesis.
@en
type
label
Fractalkine deficiency markedl ...... ne functions in atherogenesis.
@ast
Fractalkine deficiency markedl ...... ne functions in atherogenesis.
@en
prefLabel
Fractalkine deficiency markedl ...... ne functions in atherogenesis.
@ast
Fractalkine deficiency markedl ...... ne functions in atherogenesis.
@en
P2093
P2860
P1433
P1476
Fractalkine deficiency markedl ...... ne functions in atherogenesis.
@en
P2093
Israel F Charo
Liana Chan
Noah Saederup
Sergio A Lira
P2860
P304
P356
10.1161/CIRCULATIONAHA.107.743872
P407
P577
2007-12-28T00:00:00Z